ClinConnect ClinConnect Logo
Search / Trial NCT03747315

A Diagnostic Test for Familial Mediterranean Fever

Launched by HOSPICES CIVILS DE LYON · Nov 19, 2018

Trial Information

Current as of July 02, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Clinical picture compatible with an Familial Mediterranean Fever and an earlier genetic analysis finding a mutation of the MEFV gene;
  • Newly diagnosed or undergoing follow-up (without criteria of delay or evolutionary stage);
  • In the course of specific or non-specific treatment of the disease or without treatment;
  • For whom a blood test is planned as part of the routine care;
  • Of whom the informed non-opposition has been collected (parental authorization in the case of a minor patient);
  • Exclusion Criteria:
  • patient under legal protection or under safeguard of justice or any other measures of protection (guardianship, curatorship);
  • Person unable to express his consent;
  • Person in emergency situation, vital or not;
  • Infection known to HIV and / or HBV and / or HCV

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Bron, , France

Lyon, , France

Lyon, , France

Pierre Bénite, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials